Alpha 2.0
Login Register
» Articles » PMID: 17164832

Acute Kidney Injury Following Proton Pump Inhibitor Therapy

Overview
Journal Kidney Int
Publisher Elsevier
Specialty Nephrology
Date 2006 Dec 14
PMID 17164832
Citations 11
Authors
U C Brewster
M A Perazella
Affiliations
Soon will be listed here.
Citing Articles

Incidence, Pathogenesis, and Management of Proton Pump Inhibitor-Induced Nephrotoxicity.

Wei X, Yu J, Xu Z, Wang C, Wu Y Drug Saf. 2022; 45(7):703-712.

PMID: 35641849 DOI: 10.1007/s40264-022-01181-4.

Development and external validation of a diagnostic model for biopsy-proven acute interstitial nephritis using electronic health record data.

Moledina D, Eadon M, Calderon F, Yamamoto Y, Shaw M, Perazella M Nephrol Dial Transplant. 2021; 37(11):2214-2222.

PMID: 34865148 PMC: 9755995. DOI: 10.1093/ndt/gfab346.

From Biology to Clinical Practice: Iron Chelation Therapy With Deferasirox.

Palumbo G, Galimberti S, Barcellini W, Cilloni D, Di Renzo N, Elli E Front Oncol. 2021; 11:752192.

PMID: 34692534 PMC: 8527180. DOI: 10.3389/fonc.2021.752192.

A Cross-Sectional Study on Single-Day Use of Proton Pump Inhibitors in Tertiary Care Hospitals of South India.

M Z, Lavu A, Ansari M, V R, Vilakkathala R Hosp Pharm. 2021; 56(2):109-115.

PMID: 33790486 PMC: 7958368. DOI: 10.1177/0018578719873876.

Molecular pathways driving omeprazole nephrotoxicity.

Fontecha-Barriuso M, Martin-Sanchez D, Martinez-Moreno J, Cardenas-Villacres D, Carrasco S, Sanchez-Nino M Redox Biol. 2020; 32:101464.

PMID: 32092686 PMC: 7038587. DOI: 10.1016/j.redox.2020.101464.